Matt Hill is CEO and founder of Elegen, a company committed to bringing agile development to biology. Elegen is delivering DNA with an industry-leading combination of length, speed, and accuracy. Prior to Elegen, Dr. Hill earned his PhD from Stanford and was formerly Vice President of Research and Development at Natera where he co-invented their core technology and led the deployment of that technology in Natera’s best-in-class noninvasive prenatal test used by millions to ensure healthy pregnancies, a product that enabled Natera’s 2015 IPO. An accomplished scientist, engineer, and entrepreneur, he is driven to create lasting positive impacts on the world.